SEC Filing Details
Document Details
Form
Filing Date
Apr 3, 2019
Document Date
Apr 3, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
SCHNELL DAVID
Contact Information
Investor Relations:
ir@ngmbio.com
Media Relations:
media@ngmbio.com
Toolkit